Reprogramming of antibody responses in mice is achieved via adeno-associated virus delivery of SaCas9, single guide RNA (sgRNA) and a repair template targeting immunoglobulin genes.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Jeske, A. M., Boucher, P., Curiel, D. T. & Voss, J. E. J. Immunol. 207, 755–764 (2021).
Mu, Z., Haynes, B. F. & Cain, D. W. Curr. Opin. Virol. 51, 172–178 (2021).
Nahmad, A. D. et al. Nat. Biotechnol. https://doi.org/10.1038/s41587-022-01328-9 (2022).
Balazs, A. B. et al. Nature 481, 81–84 (2011).
Brinkmann, V. & Heusser, C. H. Cell. Immunol. 152, 323–332 (1993).
Nahmad, A. D. et al. Nat. Commun. 11, 5851 (2020).
Huang, D. et al. Nat. Commun. 11, 5820 (2020).
Moffett, H. F. et al. Sci. Immunol. 4, eaax0644 (2019).
Hartweger, H. et al. J. Exp. Med. 216, 1301–1310 (2019).
Rurik, J. G. et al. Science 375, 91–96 (2022).
Gillmore, J. D. et al. N. Engl. J. Med. 385, 493–502 (2021).
Wardemann, H. et al. Science 301, 1374–1377 (2003).
Chandler, R. J., Sands, M. S. & Venditti, C. P. Hum. Gene Ther. 28, 314–322 (2017).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
H.H. and M.C.N. are co-inventors on patent applications relating to B-cell gene-editing (“Antibody gene editing in B lymphocytes,” US patent application numbers 62/877,982, 62/991,482 and 16/938,132; and “Antibody gene editing in B lymphocytes and co-expression of cargo protein,” PCT application no. PCT/US2021/23026). M.C.N. is an inventor on a patent on 3BNC117 (PTC/US2012/038400).
Rights and permissions
About this article
Cite this article
Hartweger, H., Nussenzweig, M.C. CRISPR comes a-knock-in to reprogram antibodies in vivo. Nat Biotechnol 40, 1183–1184 (2022). https://doi.org/10.1038/s41587-022-01299-x
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-022-01299-x